ID: MRFR/MED/0191-HCR | 50 Pages | Published By Rahul Gotadki on March 2023
Market Synopsis of Respiratory Therapeutic Devices Market:
The Asia Pacific Respirtory Therapeutic Devices Market is projected to reach USD 2,400 Million by 2030 at 9.56% CAGR during the forecast period 2022-2030.Respiratory therapeutic devices are the instrument or the devices used to treat the respiratory diseases. These therapeutic devices are used in the treatment of chronic and acute respiratory diseases such as Asthma, COPD, tuberculosis and many more. Increasing population has increased the pollution and different air borne disease which has serve as a driving factor for the increase in the respiratory therapeutic devices market.
Different types of respiratory therapeutic devices are present in the market. Positive airway pressure (PAP) is the most famous and widely used device in the Asia Pacific region. While high cost of the product and lack of awareness about management of respiratory diseases can hamper the growth of the market.
Study Objectives of Asia Pacific Respiratory Therapeutic Devices Market:
On regional basis Asia Pacific is segmented into Japan, China, India, Australia, Republic of Korea and Rest of Asia-Pacific. Increasing prevalence of diseases has increased the respiratory therapeutic device market. According to COPD foundation, it was estimated that 6.2% of total Asia Pacific population is suffering from COPD. And COPD will be the fifth leading cause for death till 2020. India has 30 million COPD patient while 8% of total china population is suffering from COPD due to increasing pollution.
Asia Pacific Respiratory Therapeutic Devices market has been segmented on the basis of-